Abstract
Original language | English |
---|---|
Article number | 109259 |
Journal | Cell reports |
Volume | 35 |
Issue number | 11 |
DOIs | |
Publication status | Published - 15 Jun 2021 |
Keywords
- Alzheimer's disease
- SORL1
- amyloid precursor protein
- autophagy
- endosome
- iPSC
- lysosome
Access to Document
Other files and links
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
}
In: Cell reports, Vol. 35, No. 11, 109259, 15.06.2021.
Research output: Contribution to journal › Article › Academic › peer-review
TY - JOUR
T1 - SORL1 deficiency in human excitatory neurons causes APP-dependent defects in the endolysosome-autophagy network
AU - Hung, Christy
AU - Tuck, Eleanor
AU - Stubbs, Victoria
AU - van der Lee, Sven J.
AU - Aalfs, Cora
AU - van Spaendonk, Resie
AU - Scheltens, Philip
AU - Hardy, John
AU - Holstege, Henne
AU - Livesey, Frederick J.
N1 - Funding Information: We would like to thank members of the F.J.L. group for technical support, especially Dr. Moritz Haneklaus for confirming the APOE genotype for the KOLF2 cell line. We also thank Dr. Steven Moore and Dr. Ayiba Momoh for kindly providing the APP-YFP construct as a template for cloning the APP:VN construct. C.H. is supported by a Race Against Dementia Fellowship , Alzheimer’s Research UK ( ARUK-RADF2019A-007 ), and the NIHR Great Ormond Street Biomedical Research Centre . F.J.L.’s group is supported by a Wellcome Trust Senior Investigator Award ( WT101052MA ), Great Ormond Street Children’s Charity (Stem Cell Professorship), and Alzheimer’s Research UK (Stem Cell Research Centre). J.H. is supported by the UK Dementia Research Institute , which receives its funding from DRI Ltd, funded by the UK Medical Research Council , Alzheimer's Society , and Alzheimer’s Research UK ; Medical Research Council (award number MR/N026004/1 ); Wellcome Trust (award number 202903/Z/16/Z ); Dolby Family Fund ; and National Institute for Health Research University College London Hospitals Biomedical Research Centre . H.H. is a part of the EU Joint Programme-Neurodegenerative Disease Research (JPND) Working Group SORLA-FIX under the 2019 “Personalized Medicine” call (JPND2019-466-197, ZonMW 733051110). H.H. and S.L. are recipients of ABOARD, a public-private partnership receiving funding from ZonMW (#73305095007) and Health~Holland, Topsector Life Sciences & Health (PPP-allowance; #LSHM20106). S.L. is recipient of ZonMW funding (#733050512). Schematic illustrations were created with BioRender ( https://BioRender.com ). Funding Information: We would like to thank members of the F.J.L. group for technical support, especially Dr. Moritz Haneklaus for confirming the APOE genotype for the KOLF2 cell line. We also thank Dr. Steven Moore and Dr. Ayiba Momoh for kindly providing the APP-YFP construct as a template for cloning the APP:VN construct. C.H. is supported by a Race Against Dementia Fellowship, Alzheimer's Research UK (ARUK-RADF2019A-007), and the NIHR Great Ormond Street Biomedical Research Centre. F.J.L.?s group is supported by a Wellcome Trust Senior Investigator Award (WT101052MA), Great Ormond Street Children's Charity (Stem Cell Professorship), and Alzheimer's Research UK (Stem Cell Research Centre). J.H. is supported by the UK Dementia Research Institute, which receives its funding from DRI Ltd, funded by the UK Medical Research Council, Alzheimer's Society, and Alzheimer's Research UK; Medical Research Council (award number MR/N026004/1); Wellcome Trust (award number 202903/Z/16/Z); Dolby Family Fund; and National Institute for Health Research University College London Hospitals Biomedical Research Centre. H.H. is a part of the EU Joint Programme-Neurodegenerative Disease Research (JPND) Working Group SORLA-FIX under the 2019 ?Personalized Medicine? call (JPND2019-466-197, ZonMW 733051110). H.H. and S.L. are recipients of ABOARD, a public-private partnership receiving funding from ZonMW (#73305095007) and Health~Holland, Topsector Life Sciences & Health (PPP-allowance; #LSHM20106). S.L. is recipient of ZonMW funding (#733050512). Schematic illustrations were created with BioRender (https://BioRender.com). C.H. E.T. V.S. and F.J.L. conceived and designed the experiments. C.H. E.T. and V.S. performed the experiments. C.H. E.T. and V.S. analyzed the experiments. S.J.v.d.L. C.A. R.v.S. P.S. H.H. and J.H. provided genetic data and collected and provided donor fibroblasts. C.H. and F.J.L. wrote the manuscript with input from H.H. and J.H. The authors declare no competing interests. Publisher Copyright: © 2021 The Authors Copyright: Copyright 2021 Elsevier B.V., All rights reserved.
PY - 2021/6/15
Y1 - 2021/6/15
N2 - Dysfunction of the endolysosomal-autophagy network is emerging as an important pathogenic process in Alzheimer's disease. Mutations in the sorting receptor-encoding gene SORL1 cause autosomal-dominant Alzheimer's disease, and SORL1 variants increase risk for late-onset AD. To understand the contribution of SORL1 mutations to AD pathogenesis, we analyze the effects of a SORL1 truncating mutation on SORL1 protein levels and endolysosome function in human neurons. We find that truncating mutation results in SORL1 haploinsufficiency and enlarged endosomes in human neurons. Analysis of isogenic SORL1 wild-type, heterozygous, and homozygous null neurons demonstrates that, whereas SORL1 haploinsufficiency results in endosome dysfunction, complete loss of SORL1 leads to additional defects in lysosome function and autophagy. Neuronal endolysosomal dysfunction caused by loss of SORL1 is relieved by extracellular antisense oligonucleotide-mediated reduction of APP protein, demonstrating that PSEN1, APP, and SORL1 act in a common pathway regulating the endolysosome system, which becomes dysfunctional in AD.
AB - Dysfunction of the endolysosomal-autophagy network is emerging as an important pathogenic process in Alzheimer's disease. Mutations in the sorting receptor-encoding gene SORL1 cause autosomal-dominant Alzheimer's disease, and SORL1 variants increase risk for late-onset AD. To understand the contribution of SORL1 mutations to AD pathogenesis, we analyze the effects of a SORL1 truncating mutation on SORL1 protein levels and endolysosome function in human neurons. We find that truncating mutation results in SORL1 haploinsufficiency and enlarged endosomes in human neurons. Analysis of isogenic SORL1 wild-type, heterozygous, and homozygous null neurons demonstrates that, whereas SORL1 haploinsufficiency results in endosome dysfunction, complete loss of SORL1 leads to additional defects in lysosome function and autophagy. Neuronal endolysosomal dysfunction caused by loss of SORL1 is relieved by extracellular antisense oligonucleotide-mediated reduction of APP protein, demonstrating that PSEN1, APP, and SORL1 act in a common pathway regulating the endolysosome system, which becomes dysfunctional in AD.
KW - Alzheimer's disease
KW - SORL1
KW - amyloid precursor protein
KW - autophagy
KW - endosome
KW - iPSC
KW - lysosome
UR - http://www.scopus.com/inward/record.url?scp=85107990896&partnerID=8YFLogxK
U2 - https://doi.org/10.1016/j.celrep.2021.109259
DO - https://doi.org/10.1016/j.celrep.2021.109259
M3 - Article
C2 - 34133918
SN - 2211-1247
VL - 35
JO - Cell reports
JF - Cell reports
IS - 11
M1 - 109259
ER -